Bruker Completes the Acquisition of Neurescence Inc.

BILLERICA, Massachusetts – December 5, 2022 – Bruker Corporation today announced that it has completed its acquisition of Neurescence Inc., an innovative provider of ultralight fiber-bundle MultiscopesTM for simultaneous multi-region, optical functional neuroimaging. Bruker anticipates the acquisition will bolster its position as the leading provider of freely behaving animal imaging and photostimulation, addressing diversified research needs and future trends and opening the door to advanced imaging modalities. Financial details of the transaction were not disclosed.

Based in Toronto, Canada, Neurescence was founded in 2015 by a team of scientists dedicated to developing better methods for studying the central nervous system. The company holds recent patents for simultaneous multi-region optical imaging and stable detachable fiber-lens connectors with a focus lock mechanism. Neurescence’s Chromatone system enables in vivo calcium imaging and optogenetics across multiple brain and spinal cord regions, at single-cell resolution. The use of a detector that is off-animal enables both higher frame rate capture and the use of more sensitive cameras. Neurescence combines this novel optical imaging technology with machine learning to overcome critical challenges in neuroresearch. Learn more at www.neurescence.com.